Tylenol

North Texas’ Kimberly-Clark To Acquire Tylenol Maker in $40B Deal

by | Nov 3, 2025
New Jersey-based Kenvue—which spun off from Johnson & Johnson in 2023—is the maker of Tylenol, whose active ingredient, acetaminophen, has been linked to autism by the Trump administration. Kimberly-Clark CEO Mike Hsu says the unique combination of CPG and healthcare brands "will serve billions of consumers across every stage of life."
MORE